Listen Here

| |

Actionable
Takeaways

Avoid "Annual Curiosity Revenue" in favor of deep customer relationships:

Mike warns against chasing what he calls "ACR" - contracts driven by curiosity about new technology rather than real value. Instead of racing to accumulate surface-level customers, Anomaly focuses on 1-5 anchor customers where they forward-deploy engineers and dedicate leadership attention. As Mike explained, "I'd rather take a much smaller amount of those trusted pitches... find me 10 of the right conversations, don't find me a hundred surface level conversations." In healthcare's 14-month sales cycles, shallow relationships burn runway without building sustainable growth.

Match your go-to-market strategy to industry realities, not investor expectations:

Healthcare's long sales cycles and conservative nature require a fundamentally different approach than traditional SaaS growth models. Mike structured Anomaly's capital and hiring strategy around 14-month sales cycles rather than trying to compress them. "If you know that it's a 14 month sales cycle... being realistic about those timeframes and those capital structures, you just make sure your plan on burn matches your plan on strategy." This meant hiring customer success and engineering talent before traditional sales roles, aligning team composition with the actual customer adoption process.

Segment ruthlessly based on transformation readiness:

Not every healthcare organization is ready for transformative technology. Mike emphasizes the critical need to identify whether prospects are "looking for transformation" versus "looking to automate an isolated process." He shares that distinguishing between these segments determines the entire sales approach. Organizations seeking transformation are willing to work through implementation complexity for substantial outcomes, while those seeking automation want predictable, incremental improvements. Misreading this distinction leads to failed sales cycles and misaligned product development.

Use forward-deployed engineering as a competitive advantage:

Rather than traditional customer success managers, Anomaly deploys engineers directly to customers during implementation. This approach proves particularly valuable in AI/ML applications where the technology is rapidly evolving and customer needs aren't fully defined. Mike notes, "Having engineers in that has been hugely valuable for us because we're able to really quickly deliver value, very quickly deliver outsized value." This strategy enables rapid iteration, builds deeper technical trust, and often leads to expanded contracts through demonstrated capability rather than traditional sales pitches.

Build category credibility through case studies, not connections:

In healthcare, having impressive investors or warm introductions matters far less than demonstrating proven results with known organizations. Mike emphasizes, "What you need in healthcare is slapping six case studies down the desk... show me the six organizations that I know that you work with that are going to tell me I should work with you." This insight drives Anomaly's entire early-stage strategy—prioritizing customer success and measurable outcomes over rapid customer acquisition, building the credibility foundation needed for future sales acceleration.

Conversation
Highlights

 

How Anomaly Built a Fast Growing Healthcare Payments Company by Rejecting Silicon Valley’s Growth Playbook

Healthcare burns through $800 billion annually just figuring out who pays for what. That’s roughly the size of the entire U.S. Defense Department budget—spent not on providing care, but on the administrative maze of billing and insurance claims. Mike Desjadon has spent nearly two decades watching this inefficiency drain resources from an industry meant to heal people.

In a recent episode of Category Visionaries, Mike, CEO of Anomaly, shared how he’s building a healthcare payments platform that has raised $30 million in funding by doing exactly the opposite of what most Silicon Valley startups do. Instead of racing to scale quickly, Anomaly deliberately targets just 1-5 customers at a time. Instead of hiring salespeople first, they forward-deploy engineers. And instead of fighting healthcare’s notoriously long sales cycles, they’ve built their entire business model around them.

 

The Personal Catalyst Behind a Professional Mission

Mike’s journey into healthcare payments wasn’t planned. Growing up in Philadelphia, he was “convinced until maybe I was 19 years old that I was going to play in the NFL, not realizing there aren’t a slew of, you know, super slow six foot one guys under 230 pounds that play linebacker.” After reality set in, he moved to New York for real estate work before landing at the Advisory Board Company in Washington, D.C.

But it was a personal health crisis that truly hooked him on the revenue cycle. At 21, Mike was diagnosed with a heart arrhythmia after being misdiagnosed for years. “I showed up in an emergency room in New York City at Lenox Hill and I got a bill from them and then I got a bill from the emergency provider who was an independent physician, which I was like, why am I getting two bills? Why isn’t this taken care of?”

As a confused 21-year-old, Mike didn’t pay the bills, thinking they were wrong. “You know, I go to buy my first car, I’m 24 and you know, I had to pay bills that hit my credit and I had bad credit.” This experience with healthcare’s confusing payment system sparked what would become a lifelong mission: “I just fell in love with the problem from there and I wanted to fix it.”

 

Understanding Healthcare’s Ridiculous Complexity

The scale of healthcare’s payment problem is staggering, but Mike explains it starts with one fundamental issue: “When you show up to the doctor, nobody actually really knows if anyone’s going to pay for it and if that anyone you’re insurer is going to pay for you at this point in time period. Hard stop.”

This uncertainty creates what Mike calls “the most ridiculous Rubik’s Cube you’ve literally ever seen.” When you visit a doctor, your encounter passes through multiple coding systems—ICD codes for diagnoses, CPT codes for procedures, revenue codes for billing—before anyone can determine payment. “Every insurance company has their own policies for what they’re gonna pay, when and how they match up all of those codes to what circumstance they’re actually gonna pay.”

The result? “It takes 30 days, 60 days, 90 days. And we get it wrong at least 20% of the time, meaning 20% of those encounters are initially denied.” This is where that $800 billion in administrative costs comes from—an entire apparatus built to solve a problem that shouldn’t exist in the first place.

Mike contrasts this with every other industry: “When you go to get lunch and you get a sandwich and hand them your Visa card… Visa is providing real time payment assurance right then and there to that person that, yep, that’s good for it.” In healthcare, there’s no such assurance. “They have no idea you’re going to get discharged, that bill’s going to go. They don’t get that payment insurance. They have no clue.”

 

The Anti-Silicon Valley Growth Strategy

Most healthcare AI startups chase what Mike calls “annual curiosity revenue”—contracts driven by AI hype rather than real value. “Everyone’s curious about AI. You think you could bite off a piece of problem? Sure. Like I’ll give you a shot for a year.” These companies “focus so much on top line that they do that then they end up with a lot of churn.”

Anomaly took the opposite approach. “What we wanted was a much smaller amount of very deep relationships. Like even if it was just one customer, we wanted to be sticky as all get out.” Their strategy revolves around finding 1-5 anchor customers and dedicating everything to their success: “I’m involved, my chief growth officer is involved. We forward deploy engineers into, you know, delivering them is everything to us and focus on individual customer growth.”

This approach extends to their hiring strategy. While most startups rush to hire salespeople, Mike believes that’s premature: “Good salespeople in this space need to eat. And in order for them to eat, you got to have product market fit… That is the founding team’s job to figure all that stuff out. And you’re putting salespeople in a bad position if you don’t have that figured out.”

Instead, Anomaly built what Mike calls “the right delivery team”—sales leaders who excel at consulting and customer success, plus engineers who can be forward-deployed directly to customers. “Having engineers in the loop, led by somebody on the growth side that really understands how to deliver value to big organizations was a critical go to market decision.”

 

Embracing Healthcare’s Timeline

Perhaps most importantly, Anomaly structured their entire business around healthcare’s realities rather than fighting them. Healthcare has 14-month sales cycles, and Mike sees no point in pretending otherwise: “If you know that it’s a 14 month sales cycle… maybe you can get it to 12, but still, you know, you have a full year sales cycle.”

This acceptance shaped everything from their capital structure to their investor conversations. “Being realistic about those timeframes and those capital structures, you just make sure your plan on burn matches your plan on strategy.” Rather than promising compressed timelines to investors, Mike explained how growth actually happens in healthcare and delivered on that plan.

The strategy also recognizes healthcare’s unique decision-making process. Unlike other industries where connections and investor logos might open doors, healthcare requires proof: “What you need in healthcare is slapping six case studies down the desk. Not look who my investor is, look at the conversations I can get. It’s show me the six organizations that I know that you work with that are going to tell me I should work with you because I don’t know who the hell you are.”

 

The Segmentation Challenge

One of Anomaly’s biggest go-to-market lessons involves customer segmentation. Mike learned they must “ruthlessly segment” prospects into two categories: organizations looking for transformation versus those seeking to automate isolated processes. “We can work with either. But they’re very different pitches for very different reasons.”

This segmentation challenge is complicated by healthcare’s saturated vendor landscape. As one healthcare executive told Mike, “We take 10 pitches a month from AI startups.” In this environment, Anomaly’s approach of targeting fewer, deeper conversations becomes even more critical: “Find me 10 of the right conversations, don’t find me a hundred surface level conversations. Because with a 14 month sales cycle, you’ll burn yourself out before your runways up for sure.”

 

Building Category Credibility

Mike also made strategic decisions about market positioning that prioritize long-term value over short-term revenue. Despite payers buying technology faster than providers, Anomaly chose to sell exclusively to providers: “We made a pretty hard choice a couple years back that we’re only going to sell the providers. We’re going to enable providers to eliminate the information asymmetry between them and insurance companies.”

This choice reflects Mike’s broader philosophy about understanding healthcare’s true dynamics rather than viewing it through adversarial lens. “I actually think there are far too few people who actually know what should be happening. And there probably aren’t as many malicious people as people think… that insurance company probably has absolutely no idea what they cover, none. And has a financial nut to make one, that’s pretty scary. But two, it will guide you to build a better company.”

 

The Long Game

Anomaly’s approach represents a fundamental rejection of the typical startup playbook in favor of something more sustainable. By embracing healthcare’s complexities rather than fighting them, focusing on deep customer relationships over surface metrics, and building their business model around industry realities, they’ve created what Mike believes will be lasting competitive advantages.

For healthcare founders, Mike’s advice is simple but profound: “Be in every pitch and every customer conversation.” In an industry where trust and understanding trump velocity and scale, there’s no substitute for the founder’s deep involvement in customer relationships.

As healthcare continues consuming massive resources on administrative overhead, Anomaly’s patient approach to building payment assurance technology may prove that sometimes the best way to move fast is to start slow—and build something that actually works.

 

Recommended Founder
Interviews

Alexandra Ferraro

Head of Marketing of Intelligencia AI

Beyond Perfect: Healthcare Tech Marketing That Drives Real Revenue

Jocelyn Nowak

Marketing & Sales Enablement Lead of FIGUR8

Integrity-Driven Marketing: FIGUR8’s Path to 3,000+ Clinics

Amy Brown

CEO and Founder of Authenticx

Amy Brown, CEO and Founder of Authenticx: $28 Million Raised to Build the Future of Listening AI

Alex Zekoff

CEO and Co-Founder of Thoughtful AI

Alex Zekoff, CEO and Co-Founder of Thoughtful AI: $21 Million Raised to Power the Future of Healthcare Automation

Angella Gronenthal

VP of Marketing of Nice Healthcare

Nick Soman

CEO & Founder of Decent

Nick Soman, CEO & Founder of Decent: $43 Million Raised to Build the Future of Direct Primary Care

Kevin Flyangolts

CEO and Founder of Aclid

Kevin Flyangolts, CEO & Founder of Aclid: $4 Million Raised to Build the Future of Biosecurity

Khaled Boukadoum

Founder of Torch Dental

Khaled Boukadoum, Founder of Torch Dental: $49.5 Million Raised to Transform Dental Supply Management Through Digital Innovation

Thomas Knox

CEO & Founder of VitVio

Thomas Knox, CEO & Founder of VitVio: $10 Million Raised to Transform Surgical Operations Through AI-Powered Automation

Joshua Miller

CEO and Co-Founder of Gradient Health

Joshua Miller, CEO & Co-Founder of Gradient Health: $5.7 Million Raised to Build the Future of Medical Imaging

Aasim Saeed

CEO and Founder of Amenities Health

Aasim Saeed, CEO and Founder of Amenities Health: $10 Million Raised to Build the Future of Patient Engagement

Nabeel Kaukab

Founder and CEO of Phamily

How Phamily built an eight-figure ARR healthcare company without discounting: The subsidized R&D approach | Nabeel Kaukab ($25M Raised)

Daniel Lambert

CEO of PathologyWatch

Daniel Lambert, CEO of PathologyWatch: Over $50 Million Raised to Build the Future of Digital Pathology

Corey Washington

Senior Marketing Manager of Amenities Health

Humanizing Healthcare Tech: Marketing Lessons from Amenities

Torben Nielsen

CEO & Co-Founder of Uptiv Health

Torben Nielsen, CEO of Uptiv Health: $7.5M Raised to Build the Future of Infusion Therapy Through Technology-Enabled Retail Centers

Kristen Valdes

CEO & Founder of B.well

Kristen Valdes, CEO & Founder of B.well: $100 Million Raised to Reimagine the Healthcare Experience

Viral Patel

Founder and CEO of Radish Health

Viral Patel, CEO of Radish Health: $5 Million Raised to Connect Employees with a Better Healthcare Experience

Amar Kendale

President and Co-Founder of Homeward

Amar Kendale, President & Co-Founder of Homeward: $70 Million Raised to Transform Rural Healthcare Through Technology

Ty Allen

CEO of SocialClimb

Ty Allen, CEO of SocialClimb: $12 Million Raised to Power the Future of Healthcare Marketing

Hala Borno

Founder and CEO of Trial Library

Hala Borno, Founder and CEO of Trial Library: $5M Raised to Improve Patient Recruitment and Diversity in Oncology Clinical Trials

Joe Gagnon

CEO of 1upHealth

Joe Gagnon, CEO at 1upHealth: Over $75 Million Raised to Build the Future of Healthcare Data

Matt Renfro

Co-Founder & CEO of Lynx

Matt Renfro, CEO of Lynx: $17.5 Million raised to Bring Modern Fintech to Healthcare

Kyle Kiser

CEO of Arrive Health

Kyle Kiser, CEO of Arrive Health: Over $40 Million Raised to Improve the Value of Healthcare Through Informed Decision-Making

Dr. Nan-Wei Gong

CEO and Founder of FIGUR8

Dr. Nan-Wei Gong, CEO & Founder of FIGUR8: $40 Million Raised to Build the Future of Musculoskeletal Health and Injury Data Solutions

Alfred Griffin

CEO and Co-Founder of CEO and Co-Founder

Alfred Griffin, CEO and Co-Founder of LightForce: $150 Million Raised to Power the Future of Orthodontics

Jennifer Bittinger

President and Founder of Narrativa

How Narrativa leveraged COVID-19 as a market catalyst to accelerate AI adoption in pharma | Jennifer Bittinger ($2.4M Raised)

Kourosh Davarpanah

Co-Founder and CEO of Inato

Kourosh Davarpanah, Co-Founder and CEO of Inato: Over $35 Million Raised to Build the Future of Clinical Trials

Ben Albert

CEO & Co-Founder of Upfront Healthcare

Ben Albert, CEO & Co-Founder of Upfront Healthcare: $30 Million Raised to Power the Future of Patient Engagement

Justin Dearborn

Founder & CEO of Praia Health

Justin Dearborn, Founder & CEO of Praia Health: $20 Million Raised to Build the Future of Consumer Experience in Healthcare

Samson Magid

Co-Founder and CEO of HealthSnap

Samson Magid, Co-Founder and CEO of HealthSnap: Over $12 Million Raised to Build the Future of Remote Patient Monitoring

Danny Freed

CEO & Founder of Blueprint

Danny Freed, CEO & Founder of Blueprint: $13.7 Million Raised to Build the Future of Therapist Enablement

Veer Gidwaney

CEO & Founder of Ansel Health

Veer Gidwaney, CEO & Founder of Ansel Health: $50 Million Raised to Transform Supplemental Health Insurance

Derek Streat

Co-Founder & Chief Executive Officer of Dexcare

Derek Streat, CEO of Dexcare: $110 Million Raised to Help Health Systems to Find Time for the Best Care

Todd Zion

Founder of Akston Biosciences

Todd Zion, Founder of Akston Biosciences: From a $500M Exit to Pioneering Biotech Innovation in Pet Health

Verena Gerhardus

Director of Growth of Nelly Solutions

How Nelly Grew 3X Through Meta Ads in Health Tech

Brett Kleger

CEO of Datacubed Health

Brett Kleger, CEO of Datacubed Health: $43 Million Raised to Revolutionize Clinical Trial Data Collection

Cesar Herrera

CEO and Co-Founder of Yuvo Health

Cesar Herrera, CEO and Co-Founder of Yuvo Health: $28 Million Raised to Revolutionize Healthcare Access

Trenor Williams

CEO and Co-Founder of Socially Determined

Trenor Williams, CEO and Co-Founder of Socially Determined: $34 Million Raised to Build the Social Risk Intelligence Category

Stacy Edgar

CEO and Co-Founder of Venteur

Stacy Edgar, CEO & Co-Founder of Venteur: $7.6 Million Raised to Build the Future of Health Insurance

Marshall Darr

CEO & Co-Founder of StretchDollar

How StretchDollar drives leads from LLM search | Marshall Darr

Trey Sutten

CEO & Co-Founder of Siftwell Analytics

Trey Sutten, CEO & Co-Founder of Siftwell Analytics: $5 Million Raised to Transform Healthcare Analytics with AI-Powered Predictions

Joseph Schneier

CEO of Trusty Care

Joseph Schneier, CEO of Trusty Care: $13+ Million Raised to Shape the Future of Medicare

Daniel West

CEO of Prospection

Daniel West, CEO of Prospection: $36 Million Raised to Build the Future of Patient-Centric Intelligence

David King Lassman

Founder of GigXR

David King Lassman, Founder of GigXR: $7 Million Raised to Bring Immersive Learning to Healthcare

Cody Simmons

CEO of DermaSensor

Cody Simmons, CEO of DermaSensor: $36 Million Raised to Build the First AI-Powered Skin Cancer Detection Tool for Primary Care

Elad Ferber

CEO & Co-Founder of Synthpop

Elad Ferber, CEO & Co-Founder of Synthpop: $8 Million Raised to Build the Future of Healthcare Administration with AI

Richard Queen

CEO and Co-Founder of DignifiHealth

Richard Queen, CEO and Co-Founder of DignifiHealth: $7 Million Raised to Drive Better Patient Outcomes in Rural Healthcare and Beyond

Michael Passanante

Senior Vice President of Marketing and Communications of Capital Rx

How to Build 18-Month Attribution Models That Actually Work

James Bates

CEO and Founder of AdviNOW Medical

James Bates, CEO and Founder of AdviNOW Medical: $24 Million Raised to Build the Future of AI-Powered Healthcare

Michael Gorton

Founder of Teladoc

Teladoc Founder Michael Gorton on the Early Days of Pioneering the Telemedicine Category (And What’s He’s Up to Next)

Dipanwita Das

CEO and Co-Founder of Sorcero

Dipanwita Das, CEO and Co-Founder of Sorcero: Over $20 Million Raised to Power Medical Affairs Teams of the Future

Dilpreet Sahota

CEO of Trek Health

Dilpreet Sahota, CEO of Trek Health: $3 Million Raised to Help Mental Health Providers Accept Insurance

Michael Chang

Mastering Market Fit in AI: Insights from Michael Chang, Director of Marketing at ArteraAI

Andreas Cleve

CEO and Co-Founder of Corti

Andreas Cleve, CEO and Co-Founder of Corti: $32 Million Raised to Power the Future of Patient Consultations

Senan Ebrahim

CEO & Founder of Delfina

Senan Ebrahim, CEO & Founder of Delfina: $10 Million Raised to Build the Future of Intelligent Pregnancy Care

Armon Sharei

CEO & Founder of Portal

Armon Sharei, CEO & Founder of Portal: $5 Million Raised to Power the Future of Cell Engineering

Ignacio Medrano

Founder & CMO of Savana

Ignacio Medrano, Founder & CMO of Savana: $44M Raised to Transform Healthcare Intelligence Through AI

Vicky Demas

CEO of Identifeye Health

Vicky Demas, CEO of identifeye HEALTH: $90 Million Raised to Power the Future of Retinal Imaging

Rishi Nayyar

CEO and Co-Founder of PocketHealth

Rishi Nayyar, CEO and Co-Founder of PocketHealth: $22.5 Million Raised to Power the Future of Medical Image Sharing

Brad Kittredge

CEO & Co-Founder of Brightside

Brad Kittredge, CEO & Co-Founder of Brightside: $150 Million Raised to Build the Future of Mental Healthcare

David Berry

CEO and Founder of Valo

David Berry, CEO and Founder of Valo: Over $500 Million Raised to Build the Future of Drug Discovery

Austin McChord

CEO of Casana

Austin McChord, CEO of Casana: Over $46 Million Raised to Create the Future of In-Home Health Monitoring

Dr Thomas Oakley

CEO of Feedback PLC

Dr Thomas Oakley, CEO of Feedback PLC: £20 Million Raised to Build the Future of Patient Data Sharing

Itzik Cohen

Co-Founder and CEO of PayZen

Itzik Cohen, Co-Founder and CEO of PayZen: $240 Million Raised to Build the Future of Affordable Health Care

Matthew Stoudt

CEO and Founder of AppliedVR

Matthew Stoudt, CEO and Founder of AppliedVR: Over $70 Million Raised to Build the Future of Chronic Pain Relief

Rafid Fadul

CEO and Co-Founder of Zivian Health

Rafid Fadul, CEO and Co-Founder of Zivian Health: $3 Million Raised to Power the Future of Compliant Healthcare Collaborations

Mark Lehmkuhle

CEO & Founder of Epitel

Mark Lehmkuhle, CEO & Founder of Epitel: $20 Million Raised to Build the Future of Brain Health Monitoring

Dimitrios Skaltsas

CEO & Co-Founder of Intelligencia AI

Dimitrios Skaltsas, CEO & Co-Founder of Intelligencia AI: $15.5 Million Raised to Build the Future of Drug Development

Omer Maman

VP of Marketing of Healthee

Why AI Should Enhance, Not Replace Your Marketing Team

Henry O’Connell

CEO & Founder of Canary Speech

Henry O’Connell, CEO & Founder of Canary Speech: $26 Million Raised to Build the Future of Vocal Biomarker Technology

Brock Leonti

CEO & Co-Founder of Prescribe FIT

Brock Leonti, CEO & Co-Founder of Prescribe FIT: $15 Million Raised to Build the Future of Orthopedic Care